Marshall Wace LLP raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 50.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 380,391 shares of the company's stock after acquiring an additional 128,142 shares during the quarter. Marshall Wace LLP owned approximately 0.41% of Acadia Healthcare worth $15,083,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of ACHC. Tidal Investments LLC grew its holdings in Acadia Healthcare by 7.9% during the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock valued at $296,000 after buying an additional 340 shares in the last quarter. Franklin Resources Inc. grew its stake in Acadia Healthcare by 273.1% during the 3rd quarter. Franklin Resources Inc. now owns 105,228 shares of the company's stock valued at $6,673,000 after acquiring an additional 77,027 shares in the last quarter. Oddo BHF Asset Management Sas purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth approximately $1,613,000. Principal Financial Group Inc. grew its position in shares of Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company's stock worth $41,653,000 after buying an additional 13,368 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after purchasing an additional 454,044 shares in the last quarter.
Acadia Healthcare Stock Performance
Shares of NASDAQ ACHC traded up $0.60 during mid-day trading on Wednesday, hitting $21.20. The stock had a trading volume of 4,209,325 shares, compared to its average volume of 1,577,382. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a 50 day moving average of $30.17 and a two-hundred day moving average of $39.18. The firm has a market cap of $1.95 billion, a PE ratio of 6.95, a PEG ratio of 1.46 and a beta of 1.13.
Analyst Ratings Changes
Several analysts have recently issued reports on the company. Bank of America reduced their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Barclays cut shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $43.00 to $35.00 in a report on Friday, February 28th. TD Cowen dropped their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Finally, Guggenheim assumed coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $50.39.
Check Out Our Latest Stock Analysis on ACHC
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.